BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $518,000 | -61.2% | 4,839 | -62.8% | 0.02% | -57.1% |
Q3 2021 | $1,336,000 | +18.3% | 12,994 | +1.2% | 0.04% | +55.6% |
Q2 2021 | $1,129,000 | -20.1% | 12,836 | -11.7% | 0.03% | -20.6% |
Q1 2021 | $1,413,000 | -15.6% | 14,529 | -2.7% | 0.03% | -5.6% |
Q4 2020 | $1,674,000 | +265.5% | 14,925 | +160.7% | 0.04% | +260.0% |
Q1 2019 | $458,000 | +48.2% | 5,725 | 0.0% | 0.01% | +25.0% |
Q4 2018 | $309,000 | -30.9% | 5,725 | 0.0% | 0.01% | -20.0% |
Q3 2018 | $447,000 | -42.7% | 5,725 | -53.4% | 0.01% | -44.4% |
Q2 2018 | $780,000 | -30.8% | 12,285 | 0.0% | 0.02% | -33.3% |
Q1 2018 | $1,127,000 | +79.5% | 12,285 | +47.5% | 0.03% | +92.9% |
Q4 2017 | $628,000 | +8.3% | 8,330 | 0.0% | 0.01% | +7.7% |
Q3 2017 | $580,000 | +37.4% | 8,330 | 0.0% | 0.01% | +44.4% |
Q2 2017 | $422,000 | – | 8,330 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |